Opendata, web and dolomites
H2020 projects about "hematopoietic"
The page lists 60 projects related to the topic "hematopoietic".
| # | |||
|---|---|---|---|
| 1 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 |
| 2 | TREGeneration | Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes | 2015 |
| 3 | ESATM | Embryonic stem cell origin of the adipose tissue macrophages | 2015 |
| 4 | Tolltum | Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment | 2015 |
| 5 | NovLeuReg | Identification and characterization of novel essential regulators of acute myeloid leukemia | 2016 |
| 6 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 7 | TEC_Pro | Molecular control of self-renewal and lineage specification in thymic epithelial cell progenitors in vivo. | 2015 |
| 8 | HemNichMDS | Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells in Human Myelodysplastic Syndromes. | 2015 |
| 9 | UNEXPECTED | Uncovering targets for ex vivo expansion of hematopoietic stem cells to enhance cell therapies of blood disorders | 2015 |
| 10 | INFANTLEUKEMIA | GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OFINFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA | 2016 |
| 11 | ATLAS | Bioengineered autonomous cell-biomaterials devices for generating humanised micro-tissues for regenerative medicine | 2015 |
| 12 | GvHDCure | Understanding the dynamics of the immune system to cure graft-versus-host disease (GvHD). | 2016 |
| 13 | EBOPATH | Evaluation of species-specific ebolavirus pathophysiology in xenochimeric mice | 2016 |
| 14 | NVHSC | Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias | 2016 |
| 15 | MicroNICHE | Microfluidic-assisted fabrication of artifical microniches for bone marrow stem cells | 2016 |
| 16 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 17 | ILC_REACTIVITY | Biological Determinants of ILC Reactivity for Immune Responses in Health and Disease | 2016 |
| 18 | FatemapB | High Resolution Mapping of Fetal and Adult B Cell Fates During Ontogeny | 2017 |
| 19 | ResidentMacroPhage | Development, maintenance and functions of Resident Macrophages. | 2016 |
| 20 | GENE FOR CURE | Expanding and extending gene therapy of monogenic diseases of the haematopoietic system | 2016 |
| 21 | MAMLE | Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution | 2017 |
| 22 | LEUKEMIC-TEs | Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia | 2017 |
| 23 | PROGLUTASIS | Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis | 2017 |
| 24 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 25 | miRStem | Reprogramming of elite B cells to induced hematopoietic stem cell with microRNAs and transcription factors | 2017 |
| 26 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 27 | HemTree2.0 | Single cell genomic analysis and perturbations of hematopoietic progenitors: Towards a refined model of hematopoiesis | 2017 |
| 28 | BARCODED-CELLTRACING | Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system | 2017 |
| 29 | OVO-GROWTH | Oogenesis spotlighted: making mature human oocytes | 2017 |
| 30 | LUPUSCARE | PRECISION CARE IN SYSTEMIC AUTOIMMUNITY: AN INTEGRATED MULTI-TISSUE/LEVEL APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | 2017 |
| 31 | deFIBER | Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment | 2018 |
| 32 | VitASTEM | Regulation of Single Hematopoietic Stem Cells by Intake of Vitamin A | 2018 |
| 33 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 34 | CRISS | CRISPR Gene Correction for Severe Combined Immunodeficiency Caused by Mutations in Recombination-activating gene 1 and 2 (RAG1 and RAG2) | 2017 |
| 35 | RECOMB | Stem-cell based gene therapy for recombination deficient SCID (RECOMB) | 2018 |
| 36 | bloodANDbone | Blood and bone – conjoined twins in health and disease: bone marrow analogs for hematological and musculoskeletal diseases | 2018 |
| 37 | MicroBar | Microsatellite Barcoding: reconstructing the family tree of hematopoietic cells | 2018 |
| 38 | MASTFAST | Rapid production of HUMAN MAST CELLS | 2017 |
| 39 | CXCR4THERAPY | IMPROVING HEMATOPOIETIC STEM CELL- BASED GENE THERAPY OUTCOME BY MODULATING CXCR4 EXPRESSION | 2018 |
| 40 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 41 | TFs-HSCs | The identification of the Combinatorial Transcription Factor network exerting different roles in Hematopoietic Stem Cells. | 2019 |
| 42 | MIN4ALD | Use of MIN-102 for the treatment of children with cerebral ALD | 2018 |
| 43 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 44 | BloodVariome | Genetic variation exposes regulators of blood cell formation in vivo in humans | 2018 |
| 45 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 46 | RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials | 2019 |
| 47 | ImmuNiche | Identifying spatial determinants of immune cell fate commitment | 2019 |
| 48 | ADIMMUNE | Decoding interactions between adipose tissue immune cells, metabolic function, and the intestinal microbiome in obesity | 2019 |
| 49 | ImmunoStem | Dissecting and Overcoming Innate Immune Barriers for Therapeutically Efficient Hematopoietic Stem Cell Gene Engineering | 2019 |
| 50 | SingleCellAI | Deep-learning models of CRISPR-engineered cells define a rulebook of cellular transdifferentiation | 2019 |
| 51 | PMLingAML | Using PML nuclear body biology to identify potential AML treatment targets | 2020 |
| 52 | GT-GM1 | Ex vivo gene therapy for GM1-gangliosidosis | 2020 |
| 53 | ARCH | AGE-RELATED CHANGES IN HEMATOPOIESIS | 2019 |
| 54 | CompHematoPathology | Computational Hematopathology for Improved Diagnostics | 2020 |
| 55 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
| 56 | LINKER | Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 |
| 57 | IC-CCD-qHSC | Intrapopulation communication and collective cell decisions of hematopoietic stem cells | 2020 |
| 58 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
| 59 | ChRONAM-H | Chromatin Regulation Of Normal And Malignant Haematopoiesis | 2020 |
| 60 | SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers | 2020 |